Design, synthesis and antitumor activity of new naproxen based 1,2,4-triazole-Schiff base derivatives

被引：0
作者：
Alsenani N.I. [1 ]
机构：
[1] Department of Chemistry, Faculty of Science, Albaha University, P.O. Box 1988, Al Baha
来源：
Journal of Umm Al-Qura University for Applied Sciences | 2023年 / 9卷 / 3期
基金：
英国科研创新办公室;
关键词：
1,2,4-Triazole; Antitumor; Naproxen; Pharmacokinetics; Schiff base;
D O I：
10.1007/s43994-023-00044-7
中图分类号：
学科分类号：
摘要：
In the present work, new Naproxen based 1,2,4-triazole-Schiff base derivatives have been synthesized and screened for in vitro antitumor activity and in silico pharmacokinetic studies. The structure of the newly synthesized compounds (5–12) was elucidated by IR, NMR and mass spectrometry. All the compounds were tested against breast MCF-7, hepatocellular Huh-7 and lung A-549 cancer cell lines using MTT assay. Compound 7 was better in killing A549 cells with IC50 3.71 µM (1.48 fold), compared with Doxorubicin (IC50 5.50 µM). Also, compound 7 was found to be non toxic on MRC-5 normal cells as it depicts IC50 more than 500 μM. Besides, compound 12 also revealed promising activity with IC50 6.94 and 3.33 µM against MCF-7 and Huh-7 respectively. The in silico studies displayed that the synthesized compounds favors the desired pharmacokinetic profile and drug likeness properties. It can be concluded that these new Naproxen based 1,2,4-triazole-Schiff base derivative (7) has the potential to be further investigated as lead molecule in the development of new chemotherapeutic agent. © 2023, The Author(s).
引用
收藏
页码：294 / 303
页数：9
相关论文
共 37 条
  • [1] Siegel R.L., Miller K.D., Jemal A., Cancer statistics, CA Cancer J Clin, 69, pp. 7-34, (2019)
  • [2] Alam M.M., Malebari A.M., Nazreen S., Neamatallah T., Almalki A.S.A., Elhenawy A.A., Obaid R.J., Alsherif M.A., Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells, Bioorg Med Chem, 38, (2021)
  • [3] Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Pineros M., Global cancer observatory: Cancer today, International Agency for Research on Cancer, Lyon., (2020)
  • [4] Lorenzoni V., Chaturvedi A.K., Vignat J., Laversanne M., Bray F., Vaccarella S., The current burden of oropharyngeal cancer: a global assessment based on GLOBOCAN 2020, Cancer Epidemiol Biomarkers Prev, (2020)
  • [5] Almalki A.S.A., Nazreen S., Malebari A.M., Ali N.M., Elhenawy A.A., Alghamdi A.A., Ahmad A., Alfaifi S.Y.M., Alsharif M.A., Alam M.M., Synthesis and biological evaluation of 1,2,3-triazole tethered thymol-1,3,4-oxadiazole derivatives as anticancer and antimicrobial agents, Pharmaceuticals, 14, pp. 866-886, (2021)
  • [6] Alghamdi A.A., Nazreen S., Synthesis, characterization and cytotoxic study of 2-hydroxy benzothiazole incorporated 1,3,4-oxadiazole derivatives, Egypt J Chem, 63, pp. 471-482, (2020)
  • [7] El-Sayed A.A., El-Hashash M.A., El-Sayed W.M., Antiproliferative activity, and apoptotic profile of new derivatives from the meta stable benzoxazinone scaffold, Anticancer Agents Med Chem, 22, pp. 1226-1237, (2022)
  • [8] Han M.I., Bekci H., Uba A.I., YildrimY K.E., Cumaoglu A., Karasulu H.Y., Yelecksi K., Yilmaz O., Kucukguzel S.G., Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4-triazole containing hydrazide–hydrazones derived from (S)-naproxen, Arch Pharm, 352, (2019)
  • [9] Birgul K., Yildirim Y., Karasulu H.Y., Karasulu E., Uba A.I., Yelekci K., Bekci H., Cumaoglu A., Kabasakal L., Yilmaz O., Kucukguzel S.G., Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives, Eur J Med Chem, 208, (2020)
  • [10] Khalifa M.M., Ismail M.M., Eissa S., Ammar Y., Design and synthesis of some novel 6-methoxynaphthalene derivatives with potential anticancer activity, Der Pharma Chem, 4, pp. 1552-1566, (2012)
1234